Norman Maurice Rowe, M.D., MHA., L.L.C. v. Oxford Health Insurance Company, Inc.

CourtDistrict Court, E.D. New York
DecidedSeptember 27, 2024
Docket1:21-cv-06290
StatusUnknown

This text of Norman Maurice Rowe, M.D., MHA., L.L.C. v. Oxford Health Insurance Company, Inc. (Norman Maurice Rowe, M.D., MHA., L.L.C. v. Oxford Health Insurance Company, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Norman Maurice Rowe, M.D., MHA., L.L.C. v. Oxford Health Insurance Company, Inc., (E.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------------------------------X NORMAN MAURICE ROWE, M.D., MHA., L.L.C., et al.,

Plaintiffs,

ORDER -against- 21 CV 6290 (WFK) (CLP)

OXFORD HEALTH INSURANCE COMPANY, INC., et al.,

Defendants. ----------------------------------------------------------X POLLAK, United States Magistrate Judge:

On September 13, 2021, plaintiffs Norman Maurice Rowe, M.D., M.H.A., LLC (“Rowe LLC”) and East Coast Plastic Surgery P.C. (“ECPS”) (together, “plaintiffs”) commenced this action against Oxford Health Insurance Company, Inc., Oxford Health Plans (NJ), Inc., Oxford Health Plans (NY), Inc., and Oxford Health Plans LLC (collectively, “Oxford” or “defendants”) in New York Supreme Court, Queens County. (Notice of Removal ¶ 1 (ECF No. 1)). Currently pending before this Court is defendant Oxford’s Motion to Compel (“Motion”) certain discovery responses. For the reasons set forth below, the Court grants in part and denies in part defendants’ Motion. FACTUAL AND PROCEDURAL BACKGROUND Plaintiffs allege that they are a Professional Services Company, affiliated with Dr. Norman Rowe and Dr. Charles Pierce,1 considered by Oxford to be out-of-network providers. (Compl.2 ¶¶ 4-5). Plaintiffs allege that by letter dated October 5, 2020, Oxford offered to pay for

1 Neither Dr. Rowe nor Dr. Pierce are named individually in the case. 2 Citations to “Compl.” refer to plaintiffs’ Complaint filed in New York State Supreme Court, Queens County on September 13, 2021, and attached to the Notice of Removal, filed on November 11, 2021. (ECF No. 1- 1). medical services rendered to patient “M.F.” at an amount equal to “in-network” benefit levels. (Id. ¶¶ 6-7). Plaintiffs claim that based on Oxford’s offer, they provided M.F. with medical services on November 18, 2020, and billed Oxford $300,000 for services rendered. (Id. ¶¶ 9-10, 15). Plaintiffs allege claims of breach of contract based on Oxford’s ultimate reimbursement of

only $6,873.85 and its failure to pay the amount allegedly agreed to or a reasonable amount. They also allege claims of unjust enrichment, quantum meruit, aiding and abetting a breach of fiduciary duty, and a violation of New York’s prompt pay law. On November 11, 2021, the case was removed to this Court (ECF No. 1), and on January 21, 2022, Oxford moved to dismiss the Complaint, arguing that the state law claims are preempted by ERISA. (ECF No. 12). At the time of this filing, the motion to dismiss is still pending and the parties have been proceeding with discovery. More relevant to this Order, following an initial exchange of discovery requests and responses, and two conferences before this Court relating to alleged deficiencies in plaintiffs’ responses to defendants’ discovery requests, the Court directed counsel to submit letters by

December 1, 2023, concerning unresolved discovery issues. (Order, dated Nov. 1, 2023). That date was subsequently extended by the Court to allow counsel an opportunity to resolve the disputes informally, which effort was not successful. On December 22, 2023, Oxford filed the instant letter motion (the “Motion”) raising a number of disputes relating to plaintiffs’ responses to Defendants’ Amended Interrogatories and Requests for the Production of Documents. (Defs. Mot.3). Specifically, Oxford complains that plaintiffs have provided “baseless and wildly improper” objections and responses and have “improperly stonewalled” defendants’ efforts to obtain relevant factual evidence. (Id. at 4). In a response dated January 5, 2024, plaintiffs

3 Citations to “Defs. Mot.” refer to defendant Oxford’s letter motion to compel, filed December 22, 2023 (ECF No. 33). explained their objections and responses (Pls. Ltr.4), to which defendants replied in a letter dated January 16, 2024. (Defs. Reply5). For the reasons set forth below, the Court GRANTS in part and DENIES in part Oxford’s Motion.

DISCUSSION I. Legal Standard Federal Rule of Civil Procedure 26(b) governs the scope of discovery in federal cases. Rule 26(b) allows parties to “obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case.” Fed. R. Civ. P. 26(b)(1). Relevancy under Rule 26 has been “construed broadly to encompass any matter that bears on, or that reasonably could lead to other matter that could bear on, any issue that is or may be in th[e] case.” Giacchetto v. Patchogue-Medford Union Free Sch. Dist., 293 F.R.D. 112, 114 (E.D.N.Y. 2013) (alteration in original) (quoting Oppenheimer Fund, Inc. v. Sanders, 437 U.S. 340, 351 (1978)). While Rule 26(b) was amended in 2015 to move proportionality language to the provision defining the scope of discovery, “[t]he 2015 amendment[ ] . . . did not establish a

new limit on discovery.” ValveTech, Inc. v. Aerojet Rocketdyne, Inc., No. 17 CV 6788, 2021 WL 630910, at *2 (W.D.N.Y. Feb. 18, 2021); see also Robertson v. People Mag., No. 14 CV 6759, 2015 WL 9077111, at *2 (S.D.N.Y. Dec. 16, 2015) (explaining that the amendment “serves to exhort judges to exercise their preexisting control over discovery more exactingly”); Fed. R. Civ. P. 26(b)(1) advisory committee’s note to 2015 amendment (explaining that “[r]estoring the proportionality calculation to Rule 26(b)(1) does not change the existing

4 Citations to “Pls. Ltr.” refer to plaintiffs’ opposition in response to defendants’ letter motion, filed January 5, 2024 (ECF No. 34). 5 Citations to “Defs. Reply” refer to defendants’ reply in support of defendants’ letter motion, filed January 16, 2024 (ECF No. 37). responsibilities of the court and the parties to consider proportionality”). Accordingly, Rule 26 as amended “constitute[s] a reemphasis on the importance of proportionality in discovery but not a substantive change in the law.” Carl v. Edwards, No. 16 CV 3863, 2017 WL 4271443, at *2 (E.D.N.Y. Sept. 25, 2017) (quoting Vaigasi v. Solow Mgmt. Corp., No. 11 CV 5088, 2016 WL

616386, at *13 (S.D.N.Y. Feb. 16, 2016)). Nevertheless, while the scope of discovery is “broad,” it is not “limitless.” Fears v. Wilhelmina Model Agency, Inc., No. 02 CV 4911, 2004 WL 719185, at *1 (S.D.N.Y. Apr. 1, 2004). The party seeking discovery must show that it is not engaging in “merely a fishing expedition.” Carl v. Edwards, 2017 WL 4271443, at *3 (quoting Barbara v. MarineMax, Inc., No. 12 CV 368, 2013 WL 1952308, at *2 (E.D.N.Y. May 10, 2013)). The Rule requires courts to limit the extent of discovery where “the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive.” Fed. R. Civ. P. 26(b)(2)(C). II. Analysis The Court addresses in turn each of the issues raised in the Motion and the subsequent

letters. A. Defendants’ Document Requests 1. Plaintiffs’ Redactions Defendants complain that plaintiffs have redacted a number of documents produced in response to defendants’ deficiency letter, even though the parties have entered into a Confidentiality Agreement and Stipulated Protective Order (the “Confidentiality Agreement”) that this Court “so Ordered” on February 3, 2023. (ECF No. 25).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
Norman Maurice Rowe, M.D., MHA., L.L.C. v. Oxford Health Insurance Company, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/norman-maurice-rowe-md-mha-llc-v-oxford-health-insurance-company-nyed-2024.